What they do : Ovna Medical’s technologies offer real-time detection and diagnostics of cancers and heart disease. Its core technology utilizes fiber optics for real-time collection of optical signals from sub-layers within the outer-skin tissue and underlying stroma. The technology can be used in various medical endoscopes that will help in the diagnosis and monitoring of cancers and pre-cancerous tissues. The technology will also provide solutions for cardio applications such as determination of heart disease and arterial plaque build-up.
How we helped : Texas Venture Labs’ primary focus for this deal was to develop and refine the company’s technology commercialization strategy. This was a young deal, and as such, TVL associates were instrumental in developing the business plan and pitch deck, which were used to pitch to investors and as part of a Cancer Prevention Research Institute of Texas (CPRIT) grant application.
: The most important milestone for Ovna Medical is the successful completion of a clinical trial with the British Columbia Cancer Agency, which will conclude by Q4 of 2011. Prototype development efforts will focus on applications for use with rigid and flexible endoscopes as well as application development for the user interface and diagnostic software. In 2011, Ovna Medical will also pursue numerous funding and non-dilutive grant opportunities to help advance R&D.